Affordable Access

deepdyve-link
Publisher Website

Update on treatment of uterine sarcoma.

Authors
  • Nam, Joo-Hyun
  • Park, Jeong-Yeol
Type
Published Article
Journal
Current Opinion in Obstetrics & Gynecology
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
Feb 01, 2010
Volume
22
Issue
1
Pages
36–42
Identifiers
DOI: 10.1097/GCO.0b013e328334d90f
PMID: 19923988
Source
Medline
License
Unknown

Abstract

Surgery remains the mainstay of treatment for uterine sarcoma, demonstrating a curative potential regardless of histologic type. Effective adjuvant therapy to prolong survival has not yet been established. Because neither currently available radiation therapy nor different combinations of cytotoxic chemotherapeutic agents is likely to have a major impact on the course of uterine sarcoma, alternative approaches such as molecularly targeted therapies need to be explored.

Report this publication

Statistics

Seen <100 times